Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01517971 · ClinicalTrials.gov registry record

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

A clinical trial of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
1,060
Enrollment target
1
Study location

NCT01517971: Completed study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.

NCT01517971 is a study of Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,060 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01517971, a study of Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
1,060 participants
Enrollment target
1
Study location

Study Summary

This research trial studies biomarkers in predicting the risk of cancer returning after surgery in tissue samples of patients with early-stage non-small cell lung cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer and predict how well patients will respond to treatment.

Conditions Studied

Lung Cancer

Interventions

  • OTHER laboratory biomarker analysis

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 1,060 participants
Start Date 2012-01
Est. Completion 2019-02-27
Alliance for Clinical Trials in Oncology

446 total trials

What the finished NCT01517971 record still lists

NCT01517971 is an observational study that tracks outcomes without assigning an intervention. Its 1,060 participants enrollment target places it among the larger protocols in the corpus, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (14% higher).

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.

NCT01517971 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01517971 about?

NCT01517971 is a clinical study titled "Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer". This research trial studies biomarkers in predicting the risk of cancer returning after surgery in tissue samples of patients with early-stage non-small cell lung cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about bioma...

What is the current status of trial NCT01517971?

This trial is currently completed. The enrollment target is 1,060 participants. The study started on 2012-01. Estimated completion is 2019-02-27.

What conditions does trial NCT01517971 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT01517971?

The interventions under investigation include: laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT01517971?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01517971 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01517971's enrollment target sits among peer trials

1,060 46th of 409 higher than 364 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05520762 · 1,060 participants · NA

    Hospital Airway Resuscitation Trial

  • NCT05911568 · 1,060 participants

    Treatment With Endovascular Intervention for STroke Patients With Existing Disability

  • NCT07140172 · 1,060 participants · NA

    Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

  • NCT05125302 · 1,059 participants · Phase 3

    Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01517971, the US trial registry maintained by the National Library of Medicine. NCT01517971 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.